EBT-101-001 is the first gene therapy administered intravenously designed to attack the latent HIV proviral genome with an adeno-associated virus 9 CRISPR Cas9 multiplex. The results of the phase ...

On June 18, the U.S. Food and Drug Administration (FDA) approved the first medicine to prevent HIV that only has to be taken twice a year. People who are at high risk for HIV can now take the ...

Doctors near HIV cure with ‘previously impossible’ discovery: ‘We have never seen anything close to as good’ By Diana Bruk Published June 5, 2025, 3:01 p.m. ET ...

WASHINGTON — The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global rollout that could protect millions – although it’s unclear ...

Advances in medicine mean more people are living longer with HIV. But aging with HIV comes with increased health risks, and this growing population needs specialized care that's hard to find.

Sunlenca, or lenacapavir, is the first of a new class of drugs approved by the FDA for HIV treatment. Lenacapavir is an antiretroviral drug, which works by stopping the virus from replicating to ...

Health officials from the U.S. Centers for Disease Control and Prevention (CDC) are reporting encouraging news about HIV. From 2017 to 2019, the estimated number of new infections in the U.S ...

People living with HIV have a significantly increased risk of cardiovascular disease that requires a different level of preventive management than in the general population. Last year, an HHS ...

A young man holds a red ribbon representing HIV, with an inset image of the human immunodeficiency virus. New treatments and possibly even a vaccine for HIV are on the horizon in 2025.